vs
Side-by-side financial comparison of FULTON FINANCIAL CORP (FULT) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.
FULTON FINANCIAL CORP is the larger business by last-quarter revenue ($336.2M vs $270.8M, roughly 1.2× HUTCHMED (China) Ltd). FULTON FINANCIAL CORP runs the higher net margin — 28.2% vs 0.7%, a 27.5% gap on every dollar of revenue. On growth, FULTON FINANCIAL CORP posted the faster year-over-year revenue change (4.2% vs -16.5%).
Fulton Financial Corporation is an American regional financial services holding company, headquartered in Lancaster, Pennsylvania.
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
FULT vs HCM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $336.2M | $270.8M |
| Net Profit | $94.8M | $2.0M |
| Gross Margin | — | 37.7% |
| Operating Margin | — | -13.2% |
| Net Margin | 28.2% | 0.7% |
| Revenue YoY | 4.2% | -16.5% |
| Net Profit YoY | -4.3% | -83.6% |
| EPS (diluted) | $0.55 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $336.2M | — | ||
| Q4 25 | $336.0M | $270.8M | ||
| Q3 25 | $334.6M | — | ||
| Q2 25 | $324.1M | $277.7M | ||
| Q1 25 | $318.4M | $324.5M | ||
| Q4 24 | $319.6M | — | ||
| Q3 24 | $317.7M | — | ||
| Q2 24 | $334.7M | $305.7M |
| Q1 26 | $94.8M | — | ||
| Q4 25 | $99.0M | $2.0M | ||
| Q3 25 | $100.5M | — | ||
| Q2 25 | $99.2M | $455.0M | ||
| Q1 25 | $93.0M | $11.9M | ||
| Q4 24 | $68.6M | — | ||
| Q3 24 | $63.2M | — | ||
| Q2 24 | $95.0M | $25.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | 37.7% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 48.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 41.1% |
| Q1 26 | — | — | ||
| Q4 25 | 35.7% | -13.2% | ||
| Q3 25 | 38.2% | — | ||
| Q2 25 | 37.8% | -1.3% | ||
| Q1 25 | 36.1% | -5.0% | ||
| Q4 24 | 27.0% | — | ||
| Q3 24 | 25.1% | — | ||
| Q2 24 | 30.8% | -9.0% |
| Q1 26 | 28.2% | — | ||
| Q4 25 | 29.5% | 0.7% | ||
| Q3 25 | 30.0% | — | ||
| Q2 25 | 30.6% | 163.8% | ||
| Q1 25 | 29.2% | 3.7% | ||
| Q4 24 | 21.5% | — | ||
| Q3 24 | 19.9% | — | ||
| Q2 24 | 28.4% | 8.4% |
| Q1 26 | $0.55 | — | ||
| Q4 25 | $0.53 | $0.00 | ||
| Q3 25 | $0.53 | — | ||
| Q2 25 | $0.53 | $0.52 | ||
| Q1 25 | $0.49 | $0.01 | ||
| Q4 24 | $0.36 | — | ||
| Q3 24 | $0.33 | — | ||
| Q2 24 | $0.52 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $1.4B |
| Total DebtLower is stronger | — | $93.2M |
| Stockholders' EquityBook value | $3.5B | $1.2B |
| Total Assets | $32.2B | $1.8B |
| Debt / EquityLower = less leverage | — | 0.08× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | — | $836.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $802.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $93.2M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $93.4M | ||
| Q1 25 | — | $82.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $82.1M |
| Q1 26 | $3.5B | — | ||
| Q4 25 | $3.5B | $1.2B | ||
| Q3 25 | $3.4B | — | ||
| Q2 25 | $3.3B | $1.2B | ||
| Q1 25 | $3.3B | $759.9M | ||
| Q4 24 | $3.2B | — | ||
| Q3 24 | $3.2B | — | ||
| Q2 24 | $3.1B | $740.1M |
| Q1 26 | $32.2B | — | ||
| Q4 25 | $32.1B | $1.8B | ||
| Q3 25 | $32.0B | — | ||
| Q2 25 | $32.0B | $1.8B | ||
| Q1 25 | $32.1B | $1.3B | ||
| Q4 24 | $32.1B | — | ||
| Q3 24 | $32.2B | — | ||
| Q2 24 | $31.8B | $1.3B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.08× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.11× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $8.2M |
| Free Cash FlowOCF − Capex | — | $3.4M |
| FCF MarginFCF / Revenue | — | 1.2% |
| Capex IntensityCapex / Revenue | — | 1.8% |
| Cash ConversionOCF / Net Profit | — | 4.21× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-96.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $304.5M | $8.2M | ||
| Q3 25 | $116.1M | — | ||
| Q2 25 | $91.7M | $-72.9M | ||
| Q1 25 | $703.0K | $40.3M | ||
| Q4 24 | $416.6M | — | ||
| Q3 24 | $-22.0M | — | ||
| Q2 24 | $157.8M | $-39.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | $3.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-82.2M | ||
| Q1 25 | — | $32.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-49.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.2% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -29.6% | ||
| Q1 25 | — | 10.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -16.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.8% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 3.3% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.3% |
| Q1 26 | — | — | ||
| Q4 25 | 3.08× | 4.21× | ||
| Q3 25 | 1.16× | — | ||
| Q2 25 | 0.92× | -0.16× | ||
| Q1 25 | 0.01× | 3.38× | ||
| Q4 24 | 6.07× | — | ||
| Q3 24 | -0.35× | — | ||
| Q2 24 | 1.66× | -1.54× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
